HFEA holding statement on CNR application

Date issued: 16 June 2004 1706hrs

The Human Fertilisation & Embryology Authority (HFEA) is currently considering a licence application from the Newcastle Fertility Centre at Life to make human embryonic stem cells using cell nuclear transfer - a technique also known as therapeutic cloning.

As soon as a decision has been reached the HFEA will make an announcement.

If you are a journalist but do not normally receive HFEA press releases and would like to ensure you are notified of the decision, please e-mail the press office with details of your name, publication, telephone number and e-mail address.

Information on the application can be found on our website, please look at:
https://secure.hfea.gov.uk/Research/Researchapplications,DanaInfo=www.hfea.gov.uk+

Background information on how the HFEA assesses research applications can be found on our website, please look at:
https://secure.hfea.gov.uk/PressOffice/Backgroundpapers/Humanembryoresearch,DanaInfo=www.hfea.gov.uk+

Background information on stem cell research can be found on our website, please look at: https://secure.hfea.gov.uk/PressOffice/Backgroundpapers/Stemcellresearch,DanaInfo=www.hfea.gov.uk+

Notes to editors

The HFEA was set up in August 1991 as part of the Human Fertilisation and Embryology Act 1990.  The HFEA's principal tasks are to license and monitor clinics that carry out in vitro fertilisation (IVF), donor insemination (DI) and human embryo research. The HFEA also regulates the storage of gametes (eggs and sperm) and embryos.

Ends